Globus Medical Inc
GMED· NYSE
Released Nov 6, 2025, after the close
10-Q filed Nov 6, 2025, 37 days after period end · 0001237831-25-000031
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $769.05M | $625.71M | $383.64M | $254.15M |
| Net Income | $118.97M | $51.84M | $998.00K | $47.43M |
| EPS Diluted |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| $0.88 |
| $0.38 |
| $0.01 |
| $0.47 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.